MPG.eBooks - Description: PCSK-9 inhibitors for hyperlipidemia

Read Now

Alirocumab and evolocumab are expensive drugs (annual cost per patient > Can

Bibliographic Details
Main Authors:	Banerjee, Srabani, Wells, Charlotte (Author), Grobelna, Aleksandra (Author)
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa CADTH 2017, June 6, 2017
Series:	CADTH rapid response report: summary with critical appraisal
Subjects:	Comparative Effectiveness Research Hyperlipidemias / Drug Therapy Proprotein Convertase 9 / Therapeutic Use
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK524911
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	Alirocumab and evolocumab are expensive drugs (annual cost per patient > Can
Physical Description:	1 PDF file (21 pages) illustrations